- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03079908
Comparison of da Vinci Simulator vs LapSim Simulator
March 11, 2018 updated by: Pouya Iranmanesh, Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
Comparison of the da Vinci Skills Simulator and the LapSim Laparoscopy Simulator for Conventional Laparoscopic Skills Improvement: a Prospective, Randomized Trial
Virtual reality surgical simulators (VRSS) are gaining popularity for general surgery training, both for conventional laparoscopic and robotically-assisted surgery.
Although numerous studies have analysed the impact of VRSS training on surgical skills, there is a lack of data regarding the comparison of robotic VRSS (RVRSS) and laparoscopic VRSS (LVRSS) training on conventional laparoscopic skills among subjects with no prior surgical experience.
The hypothesis of the present study is that RVRSS could improve conventional laparoscopic skills as much as laparoscopic LVRSS among naïve subjects
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Luzern, Switzerland, 6000
- Luzern Kantonsspital Luzern
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy medical students aged 20 to 30 years old
Exclusion Criteria:
- No prior surgical, laparoscopic or robotic experience
- No previously known severe learning disability or mental deficiency
- No handicap limiting the usage of one or both upper limb(s)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Da Vinci Skills Simulator®
Participants in this group will undergo robotic virtual reality surgical simulator training (Da Vinci Mimics) and will subsequently be evaluated on a dry lab laparoscopic box
|
Initial robotic virtual reality surgical simulator Training (da Vinci Skills Simulator ® System), then laparoscopic dry box evaluation
|
Active Comparator: LapSim®
Participants in this group will undergo laparoscopic virtual reality surgical simulator Training (LapSim) and will subsequently be evaluated on a dry lab laparoscopic box
|
Initial laparoscopic virtual reality surgical simulator training (LapSim ® System), then laparoscopic dry box evaluation
|
Placebo Comparator: Dry lab box laparoscopic training
Participants in this group will undergo dry lab box laparoscopic training only
|
No initial simulator training.
Dry lab box laparoscopic Training only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Exercises times
Time Frame: Within 1 day after randomization / data will be presented after completion of the study (an average of 9 months)
|
Time to realize each training exercise as well as the final evaluation exercise
|
Within 1 day after randomization / data will be presented after completion of the study (an average of 9 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Objects drops
Time Frame: Within 1 day after randomization / data will be presented after completion of the study (an average of 9 months)
|
Number of time objects were unwillingly dropped during each training exercise as well as the final evaluation exercise
|
Within 1 day after randomization / data will be presented after completion of the study (an average of 9 months)
|
Objects out of view
Time Frame: Within 1 day after randomization / data will be presented after completion of the study (an average of 9 months)
|
Number of times one or both instruments or objects used for the exercises were out of the viewing field during each training exercise as well as the final evaluation exercise
|
Within 1 day after randomization / data will be presented after completion of the study (an average of 9 months)
|
Instruments collisions
Time Frame: Within 1 day after randomization / data will be presented after completion of the study (an average of 9 months)
|
Number of collisions between the different instruments used to perform each training exercise as well as the final evaluation exercise
|
Within 1 day after randomization / data will be presented after completion of the study (an average of 9 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Andreas Scheiwiller, MD, Luzerner Kantonsspital Luzern, Switzerland
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 15, 2017
Primary Completion (Anticipated)
November 1, 2017
Study Completion (Anticipated)
June 1, 2018
Study Registration Dates
First Submitted
February 23, 2017
First Submitted That Met QC Criteria
March 8, 2017
First Posted (Actual)
March 15, 2017
Study Record Updates
Last Update Posted (Actual)
March 13, 2018
Last Update Submitted That Met QC Criteria
March 11, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- Simulator study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscopy Training
-
Copenhagen Academy for Medical Education and SimulationCompletedLaparoscopy | Simulation TrainingDenmark
-
The University of Hong KongHong Kong Jockey Club Innovative Learning Centre for MedicineCompleted
-
Tepecik Training and Research HospitalActive, not recruitingLaparoscopy | Simulation TrainingTurkey
-
Zealand University HospitalRegion Capital DenmarkCompleted
-
Unity Health TorontoCanadian Institutes of Health Research (CIHR); Royal College of Physicians...CompletedSimulation | Education | Laparoscopy | Technical Skills TrainingCanada
-
TakedaCompleted
-
Kangbuk Samsung HospitalUnknown
-
Kangbuk Samsung HospitalCompletedLaparoscopyKorea, Republic of
-
M.D. Anderson Cancer CenterTerminatedLaparoscopyUnited States
-
Marko KraljevicUniversity Hospital, Basel, SwitzerlandRecruiting
Clinical Trials on da Vinci Skills Simulator®
-
University Hospital, GenevaRecruiting
-
Johns Hopkins UniversityCompletedSurgical Simulation Education
-
University of Alabama at BirminghamCompletedHead and Neck Cancer | Hypopharyngeal Cancer | Oropharyngeal Cancer | Upper Aerodigestive Tract NeoplasmsUnited States
-
Fondation Ophtalmologique Adolphe de RothschildTerminatedPituitary NeoplasmsFrance
-
University of Maryland, BaltimoreCompletedRobotic Surgery | Renal Transplant Donor of Left Kidney | Donor Nephrectomy | Single-portUnited States
-
Intuitive SurgicalRecruiting
-
The Third Xiangya Hospital of Central South UniversityCompleted
-
Fundación de investigación HMCompleted
-
Deborah Farr, MDRecruitingBreast Cancer | High Risk of Breast CancerUnited States
-
Case Comprehensive Cancer CenterSuspendedMalignant Neoplasm of ProstateUnited States